SSKN - Mergers and acquisitions

Company focused on the large and growing peripheral artery disease (PAD) market Ra Medical Systems, Inc. (NYSE:RMED), a medical device company focused on commercializing its excimer laser system to treat vascular disease, announces the sale of its Pharos dermatology business to STRATA Skin Sciences (NASDAQ:SSKN) for $3.7 million in cash. The Pharos excimer laser is FDA-cleared for the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. "We believe this transaction is in the best interest of Ra Medical and our shareholders as we intend to maximize value with a strategy that continues to focus on the large and growing PAD market," said Will McGuire, Ra Medical Systems CEO.

Positions STRATA as the predominant provider of excimer laser treatments to address the $6 billion U.S. market for the treatment of chronic skin diseasesDelivers added long-term recurring revenue growth potential and prospective customer baseIncreases competitive positioning with more than 400 U.S. dermatology practices HORSHAM, Pa., Aug. 16, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the acquisition of the U.S. dermatology business of Ra Medical. The transaction immediately provides STRATA with the

AVENTURA, Fla.--(BUSINESS WIRE)--Accelmed Partners (“Accelmed”), a private equity firm focused on acquiring and investing in U.S. commercial stage, lower middle market HealthTech companies, today announced the successful close of its oversubscribed second fund, Accelmed Fund II, LP (“Fund II” or the “Fund”) at the Fund’s hard cap of $400 million, exceeding its original $300 million target. Fund II received significant backing from new investors globally, including pension funds, insurers, family offices, and high net worth individuals, as well as from existing Accelmed limited partners. For more than a decade, Accelmed has leveraged its deep HealthTech industry experience, operatio